UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005188
Receipt number R000006158
Scientific Title The effect of standard treatments in COPD patients without maintenance therapy.
Date of disclosure of the study information 2011/03/03
Last modified on 2015/09/03 20:38:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of standard treatments in COPD patients without maintenance therapy.

Acronym

The effect of standard treatments in COPD patients without maintenance therapy.

Scientific Title

The effect of standard treatments in COPD patients without maintenance therapy.

Scientific Title:Acronym

The effect of standard treatments in COPD patients without maintenance therapy.

Region

Japan


Condition

Condition

COPD

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy and safety of standard therapy in COPD patients without maintenance therapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of pulmonary function (trough FEV1 and trough FVC)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

Maintenance therapy in accordance with Japanese COPD guideline

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Diagnosis of COPD by respiratory specialist.
Not receiving of maintenance therapy with LABA, LAMA and ICS
Patients who are judged to be included in the study by investigator based on a preliminary clinical examination.
Written Informed Consent Form prior to participation in the trial.

Key exclusion criteria

A known hypersensitivity to the components of each standard drug for COPD.
Known diseases which contraindicate using the standard drugs for COPD according to the package insert.
Patients who are judged not to be included in the study by investigator based on a preliminary clinical examination.
Not able to follow an instruction for a smoking cessation.
A history of asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, or pulmonary thromboembolic disease.
Not able to perform pulmonary function tests.
Participation in another trial with an investigational drug within 2 month prior to informed consent visit.
Pregnant or nursing women or women of childbearing potential who are not using a medically approved means of contraception.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuhiro Setoguchi

Organization

Tokyo Medical University Hospital

Division name

Respiratory Medicine

Zip code


Address

6-7-1 Nishi-Shinjyuku, Shinjyuku-ku, Tokyo

TEL

+81-3-3342-6111

Email

ystgc@tokyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuhiro Setoguchi

Organization

Tokyo Medical University Hospital

Division name

Respiratory Medicine

Zip code


Address

6-7-1 Nishi-Shinjyuku, Shinjyuku-ku, Tokyo

TEL

+81-3-3342-6111

Homepage URL


Email

ystgc@tokyo-med.ac.jp


Sponsor or person

Institute

Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Public health research center

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 12 Month 08 Day

Date of IRB


Anticipated trial start date

2011 Year 03 Month 01 Day

Last follow-up date

2013 Year 02 Month 05 Day

Date of closure to data entry

2013 Year 03 Month 29 Day

Date trial data considered complete

2013 Year 04 Month 19 Day

Date analysis concluded

2013 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2011 Year 03 Month 03 Day

Last modified on

2015 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006158